Muhammad Areeb Ashfaq
Internal Medicine · Mobile, ALNPI 1619548450
Payments from drug & device makers
Across 74 payments — averaging $21.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$240
- Incyte Corporation$178
- Astellas Pharma US Inc$130
- E.r. Squibb & Sons, L.L.C.$119
- Novartis$108
- Johnson & Johnson$96
- plus $720 from 22 others
What the payments were for
- Food & beverage$1,49194%
- Education$1006%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $240 |
| Incyte Corporation | 11 | $178 |
| Astellas Pharma US Inc | 2 | $130 |
| E.r. Squibb & Sons, L.L.C. | 5 | $119 |
| Novartis | 5 | $108 |
| Johnson & Johnson | 5 | $96 |
| Eisai Inc. | 5 | $89 |
| Lilly USA, LLC | 3 | $77 |
| Merck | 3 | $63 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $63 |
| Pfizer | 3 | $48 |
| Exelixis Inc. | 2 | $44 |
| Sanofi | 2 | $34 |
| Genentech USA, Inc. | 1 | $28 |
| EMD Serono, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Tersera Therapeutics LLC | 1 | $24 |
| Array Biopharma Inc | 1 | $23 |
| GSK | 1 | $20 |
| Pharmaessentia USA Corporation | 1 | $18 |
| Genmab U.S., Inc. | 1 | $18 |
| Sobi, Inc | 1 | $17 |
| Gilead | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Syndax Pharmaceuticals, Inc. | 1 | $17 |
| ADC Therapeutics America, Inc. | 1 | $17 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
How this compares
$1,591 in reported general payments places this provider in the 65th percentile of 1,533 internal medicine providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 16 | $114 |
| Amlodipine Besylate | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Mobile
- Harry StuddardMobile$12.9M
- Thomas McKelveyMobile$365K
- Mary HonkanenMobile$302K
- Bobby WrightsMobile$89K
- Rahel AzizMobile$67K
- Jamie CaudillMobile$52K
- Thomas GarthMobile$48K
- Lin LiMobile$45K
- Edward CarlosMobile$26K
- Donald SandersMobile$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.